The Asia Pacific market for CRM devices will expand through 2026, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. The uptake of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will also boost revenues.

This Medtech 360 Report provides key market metrics for the  CRM devices in Asia Pacific markets, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.

Table of contents

  • Cardiac Rhythm Management Devices - Market Insights - Asia Pacific (Supplemental)

Author(s): Swarnadip Dutta, MBA

Swarnadip Dutta is a team lead within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the fields of dental implants, joint reconstruction, and craniomaxillofacial devices. Swarnadip holds a Master's degree in Bioinformatics and Biotechnology from SRM University, an MBA in Operations Management, and a Six Sigma Green Belt certification from the Indian Statistical Institute.

Follow Swarnadip on Twitter: @Swarnadip_DRG.


Related Reports

Cardiac Rhythm Management Devices - Market Insights - Europe

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the European

View Details

Cardiac Rhythm Management Devices - Market Insights - United States

The mature US CRM device market will remain fairly flat through 2028, seeing rising

View Details

Cardiac Rhythm Management Devices - Market Insights - Latin America (Supplemental)

The Latin American market for CRM devices will experience modest growth through 2026, driven primarily by an aging population, the in...

View Details

Cardiac Rhythm Management Devices - Market Insights - Europe (Supplemental)

The mature European CRM device market will remain flat through 2026, as a result of flat generator unit sales, rising 

View Details